BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Roche Palo Alto 

3431 Hillview Avenue

Palo Alto  California  94304  U.S.A.
Phone: 650-855-5050 Fax: n/a


SEARCH JOBS
Roche Palo Alto is committed to innovation in discovering and developing medicines that improve the lives of people with inflammatory or viral diseases ranging from asthma, chronic obstructive pulmonary disease (COPD) and rheumatoid arthritis to the hepatitis C virus and other viruses.

Our park-like campus blends the best of two worlds: the flexibility and vigor of a small biotechnology company and the resources and rigor of a large, multi-national pharmaceutical corporation.

Roche Palo Alto is one of five global research sites for the Swiss-based healthcare company Roche. Our 1,000 scientists and staff lead the discovery, development and strategic marketing of medicines to improve the lives of people affected by serious illness. We do this in a responsible and ethical manner with a commitment to sustainable development that respects the needs of the individual, society and environment.

We have ongoing opportunities for research scientists and research associates in multiple disciplines, including medicinal and analytical chemistry, and molecular and cell biology. Other key positions crucial to our success include professionals in the areas of environmental health and safety, finance, human resources, information technology, intellectual property, legal and quality assurance, public affairs and site services. We also sponsor summer internships for undergraduate students in the sciences and business.

Our compensation philosophy allows us to recruit top talent by providing competitive pay opportunities within the pharmaceutical and biotech industry. Our comprehensive employee benefit program is designed to meet competitive needs and, most importantly, the needs of employees and their families with respect to health care, death, disability, retirement, and an opportunity for rest and relaxation away from the job.

Roche Palo Alto also offers a range of on site amenities – including a fitness center, cafeteria, commuter checks program and convenient access to services such as dental care, car washes, haircuts, oil changes, dry cleaning and eWaste recycling.

To get to know more about the exciting career opportunities we offer, and see why Roche Palo Alto is an outstanding place to work, please visit our web site at http://paloalto.roche.com/


 Key Statistics


Email: paloalto.panews@roche.com
Ownership: Subsidiary

Web Site: Roche Palo Alto
Employees: 1200
Symbol: RHHBF.PK
 



Industry
Big Pharma






 Company News
More Layoffs Coming at Roche Palo Alto (RHHBF.PK) 7/27/2009 7:31:25 AM    More...
U.S. Federal Circuit Court Affirms Judgment for Allergan Inc. (AGN) and Roche Palo Alto (RHHBF.PK) against Apotex Inc., Apotex Corp.., and Novex Pharma in Ketorolac Patent Infringement Lawsuit 4/12/2007 12:33:45 PM    More...
Roche And KOSAN Biosciences, Inc. (KOSN) Breast Cancer Phase II Trial To Proceed 10/19/2005 5:13:12 PM    More...
Hoffmann-La Roche (New Jersey) (RHHBY) And GlaxoSmithKline (GSK) Annouce FDA Approves Once-Monthly Boniva(R) For Osteoporosis First-Ever Monthly Single Tablet For Any Disease 10/19/2005 5:13:07 PM    More...
Roche (RHHBY) Announces New Study To Evaluate Pegasys And Copegus To Treat Hepatitis C In Liver Transplant Patients 10/19/2005 5:13:05 PM    More...
Roche (RHHBY) Release: FDA Approves Pegasys And Copegus As Only Hepatitis C Treatment For HIV Patients 10/19/2005 5:12:51 PM    More...
Roche (RHHBY) New Data On Most Prescribed Hepatitis C Therapy Pegasys(R) Presented At European Association For The Study Of The Liver Conference 10/19/2005 5:12:42 PM    More...
Patients Urged To Follow Painkiller Labels 10/19/2005 5:12:31 PM    More...
FDA Warns Naproxen Users; Bayer Healthcare's Aleve Latest Drug To Draw Scrutiny 10/19/2005 5:12:30 PM    More...
Roche (RHHBY) Release: U.S. FDA Approves New 500 Mg Tablet Formulation Of INVIRASE(R) 10/19/2005 5:12:30 PM    More...
12

//-->